ENDOMETRIAL MIXED CELL ADENOCARCINOMA

Clinical trials for ENDOMETRIAL MIXED CELL ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL MIXED CELL ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for ENDOMETRIAL MIXED CELL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet finished but already full! 2 Completed 1

New drug tested to fight spreading uterine cancer

Disease control Completed

This study tested whether the drug cabozantinib could help control advanced endometrial cancer that had returned or spread. It involved 102 women whose cancer had progressed after prior chemotherapy. The drug works by trying to cut off the tumor's blood supply and block signals t…

Matched conditions: ENDOMETRIAL MIXED CELL ADENOCARCINOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

ENDOMETRIAL MIXED CELL ADENOCARCINOMA

Get alerted when new ENDOMETRIAL MIXED CELL ADENOCARCINOMA trials appear

New drug tested to fight spreading uterine cancer